Emerald Mutual Fund Advisers Trust’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
– Sell
-17,116
Closed -$594K – 264
2019
Q4
$594K Hold
17,116
– – 0.02% 196
2019
Q3
$542K Buy
+17,116
New +$674K 0.02% 191

Other funds holding HCAT

Emerald Mutual Fund Advisers Trust's HCAT Position: Q1 2020 in Review

Emerald Mutual Fund Advisers Trust sold out of Health Catalyst (HCAT) in Q1 2020, closing a stake of 17,116 shares — an estimated $594K sold.

Emerald Mutual Fund Advisers Trust first reported a position in HCAT in Q3 2019 and held it in 2 quarters. The position peaked at $594K in Q4 2019. 109 funds tracked by Wall St. Rank hold HCAT as of Q1 2020.

  • Emerald Mutual Fund Advisers Trust reported no remaining Health Catalyst position as of Q1 2020 after selling out during the quarter.
  • Emerald Mutual Fund Advisers Trust sold 17,116 Health Catalyst shares in Q1 2020, an estimated $594K.
  • Emerald Mutual Fund Advisers Trust first reported a position in Health Catalyst in Q3 2019 and held it in 2 quarters.
  • Emerald Mutual Fund Advisers Trust's Health Catalyst position peaked at $594K in Q4 2019.
  • 109 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2020.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q1 2020, filed 30 Apr 2020.